A detailed history of Met Life Investment Management, LLC transactions in Omeros Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 34,726 shares of OMER stock, worth $234,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,726
Previous 34,726 -0.0%
Holding current value
$234,400
Previous $140,000 2.14%
% of portfolio
0.0%
Previous 0.0%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.04 - $4.23 $41,374 - $57,570
13,610 Added 64.45%
34,726 $140,000
Q1 2024

May 14, 2024

BUY
$2.88 - $4.89 $60,814 - $103,257
21,116 New
21,116 $72,000
Q3 2023

May 09, 2024

BUY
$2.81 - $5.69 $90,667 - $183,593
32,266 New
32,266 $94,000
Q2 2023

Apr 29, 2024

BUY
$4.45 - $7.57 $143,583 - $244,253
32,266 New
32,266 $175,000
Q2 2023

Aug 10, 2023

BUY
$4.45 - $7.57 $143,583 - $244,253
32,266 New
32,266 $175,000
Q2 2022

Aug 11, 2022

SELL
$1.92 - $6.28 $55,616 - $181,912
-28,967 Closed
0 $0
Q1 2022

May 10, 2024

BUY
$5.07 - $7.2 $146,862 - $208,562
28,967 New
28,967 $174,000
Q1 2022

Jun 20, 2023

BUY
$5.07 - $7.2 $146,862 - $208,562
28,967 New
28,967 $174,000
Q1 2022

Mar 22, 2023

BUY
$5.07 - $7.2 $85,490 - $121,406
16,862 Added 139.3%
28,967 $174,000
Q1 2022

May 12, 2022

BUY
$5.07 - $7.2 $85,490 - $121,406
16,862 Added 139.3%
28,967 $174,000
Q4 2021

May 17, 2024

SELL
$5.67 - $8.54 $62,676 - $94,401
-11,054 Reduced 47.73%
12,105 $77,000
Q4 2021

Jun 21, 2023

BUY
$5.67 - $8.54 $68,635 - $103,376
12,105 New
12,105 $77,000
Q4 2021

Mar 22, 2023

SELL
$5.67 - $8.54 $62,676 - $94,401
-11,054 Reduced 47.73%
12,105 $77,000
Q4 2021

Feb 15, 2022

SELL
$5.67 - $8.54 $62,676 - $94,401
-11,054 Reduced 47.73%
12,105 $78,000
Q3 2021

Jun 21, 2023

BUY
$13.4 - $16.3 $310,330 - $377,491
23,159 New
23,159 $319,000
Q2 2021

Jun 21, 2023

BUY
$14.81 - $19.13 $342,984 - $443,031
23,159 New
23,159 $343,000
Q1 2021

May 17, 2024

BUY
$14.52 - $23.53 $29,664 - $48,071
2,043 Added 9.68%
23,159 $412,000
Q1 2021

Jun 26, 2023

BUY
$14.52 - $23.53 $336,268 - $544,931
23,159 New
23,159 $412 Million
Q1 2021

Mar 22, 2023

SELL
$14.52 - $23.53 $55,539 - $90,002
-3,825 Reduced 14.18%
23,159 $412,000
Q1 2021

May 14, 2021

SELL
$14.52 - $23.53 $55,539 - $90,002
-3,825 Reduced 14.18%
23,159 $412,000
Q4 2020

Jun 22, 2023

BUY
$10.14 - $15.19 $273,617 - $409,886
26,984 New
26,984 $385,000
Q3 2020

Jun 26, 2023

BUY
$9.57 - $21.32 $258,236 - $575,298
26,984 New
26,984 $272,000
Q2 2020

May 24, 2024

BUY
$12.21 - $16.99 $71,648 - $99,697
5,868 Added 27.79%
26,984 $397 Million
Q2 2020

Jun 26, 2023

BUY
$12.21 - $16.99 $329,474 - $458,458
26,984 New
26,984 $397,000
Q2 2020

Mar 22, 2023

BUY
$12.21 - $16.99 $67,448 - $93,852
5,524 Added 25.74%
26,984 $397,000
Q2 2020

Aug 14, 2020

BUY
$12.21 - $16.99 $67,448 - $93,852
5,524 Added 25.74%
26,984 $397,000
Q1 2020

Jul 12, 2023

BUY
$9.03 - $19.72 $193,783 - $423,191
21,460 New
21,460 $286,000
Q4 2019

Jul 12, 2023

BUY
$13.01 - $17.15 $279,194 - $368,038
21,460 New
21,460 $302,000
Q3 2019

Jul 12, 2023

BUY
$14.55 - $20.56 $312,243 - $441,217
21,460 New
21,460 $350,000
Q2 2019

Jul 12, 2023

BUY
$15.0 - $19.62 $321,900 - $421,045
21,460 New
21,460 $336,000
Q1 2019

Jul 13, 2023

BUY
$11.65 - $17.72 $250,009 - $380,271
21,460 New
21,460 $372,000
Q4 2018

Jul 13, 2023

BUY
$10.72 - $16.73 $230,051 - $359,025
21,460 New
21,460 $239,000
Q4 2018

Mar 22, 2023

SELL
$10.72 - $16.73 $126,077 - $196,761
-11,761 Reduced 35.4%
21,460 $239,000
Q4 2018

Feb 14, 2019

SELL
$10.72 - $16.73 $126,077 - $196,761
-11,761 Reduced 35.4%
21,460 $239,000
Q3 2018

Jul 13, 2023

BUY
$17.73 - $26.69 $380,485 - $572,767
21,460 New
21,460 $523,000
Q3 2018

Mar 22, 2023

BUY
$17.73 - $26.69 $589,008 - $886,668
33,221 New
33,221 $810,000
Q3 2018

Nov 14, 2018

BUY
$17.73 - $26.69 $208,522 - $313,901
11,761 Added 54.8%
33,221 $811,000
Q4 2017

Feb 15, 2018

BUY
$13.26 - $22.86 $284,559 - $490,575
21,460
21,460 $417,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $423M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.